chrisvoncsefalvay/vaers-outcomes huggingface dataset:
An accident and fractured her toe and sprained her ankle; Vertigo; Drowsiness; Dizziness; Worst headache she had in 6 months; Extreme nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ACCIDENT AT HOME (An accident and fractured her toe and sprained her ankle), VERTIGO (Vertigo), SOMNOLENCE (Drowsiness), DIZZINESS (Dizziness) and HEADACHE (Worst headache she had in 6 months) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Knee replacement (She has a titanium knee), Arthritis and X-ray on 03-Mar-2021.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 02-Mar-2021, the patient experienced ACCIDENT AT HOME (An accident and fractured her toe and sprained her ankle), VERTIGO (Vertigo), SOMNOLENCE (Drowsiness), HEADACHE (Worst headache she had in 6 months) and NAUSEA (Extreme nausea). 02-Mar-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, ACCIDENT AT HOME (An accident and fractured her toe and sprained her ankle), VERTIGO (Vertigo), SOMNOLENCE (Drowsiness), DIZZINESS (Dizziness) and HEADACHE (Worst headache she had in 6 months) outcome was unknown and NAUSEA (Extreme nausea) had not resolved.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.
After receiving the vaccination patient had to wait 20 to 25. Her arm was sore and red. The muscle became tender. She received a numb and tingly feeling. Where the injection was entered arm started to knot up. The inside of body felt hot. Patient developed chills and developed chills. Felt nausea. Started feeling flu like symptoms that lasted four days. The next day hair was coming out from the roots. The hair dresser called it shedding.
10 months old patient was administered Kinrix; Kinrix was the patient's 3rd dose of DTaP and IPV; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 10-month-old female patient who received DTPa-IPV (Kinrix) (batch number e2l54, expiry date 31st March 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 28th April 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 28th April 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 28-Apr-2022 Reporter's Comments: The reporter stated that on the day of reporting, a 10 months old patient was administered Kinrix instead of Pentacel. During call with 2nd line agent HCP stated that she believed they were doing catch up for the 6 month vaccines and that the Kinrix was the patient's 3rd dose of DTaP and IPV. The reporter consented to follow up. Additional Supportive Information: The 10 months old patient was administered Kinrix as 3rd dose of series instead of Pentacel, which led to inappropriate age at vaccine administration, inappropriate schedule of vaccine.
Painful red area beneath where vaccine was given. Encompassing bicep area. Abx prescribed.
GOING THROUGH THE SAME PAIN ALL THE TIME; UNABLE TO FUNCTION; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced going through the same pain all the time, and unable to function. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from unable to function, and going through the same pain all the time. This report was non-serious.
sore throat; chills; cough; shortness of breath; headache; body aches; This is a spontaneous report from a contactable consumer (patient). A 67-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 10Mar2021 (at the age of 67 years old) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 13Mar2021, the patient experienced sore throat, chills, cough, shortness of breath, headache and body aches. Outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
ACUTE CORONARY SYNDROME, UNSPECIFIED 6/13/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  HYPOTENSION 6/12/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  CARDIOGENIC SHOCK 6/13/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA
Abdominal pain; Sweats; Chills; A fever of >100; Headache; Fatigue/tiredness; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Abdominal pain), HYPERHIDROSIS (Sweats), CHILLS (Chills), PYREXIA (A fever of >100) and HEADACHE (Headache) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN (Abdominal pain), HYPERHIDROSIS (Sweats), CHILLS (Chills), PYREXIA (A fever of >100), HEADACHE (Headache), FATIGUE (Fatigue/tiredness) and MYALGIA (Muscle aches). At the time of the report, ABDOMINAL PAIN (Abdominal pain), HYPERHIDROSIS (Sweats), CHILLS (Chills), PYREXIA (A fever of >100), HEADACHE (Headache), FATIGUE (Fatigue/tiredness) and MYALGIA (Muscle aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: >100 (High) a fever of >100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
After 5 mins of getting the 1st shot I felt an allergic reaction little bit hard to breathe and hot flash.  I told the pharmacist and was advised to stay an extra 10 minutes.  I left the Pharmacy and proceeded to the store and then home.  Over the next 1.5 days I felt a sort of brain fog, my arm puffed up red about the size of a half dollar.  The brain fog went away and then for the next 2-3 days  my body felt like I was coming down with a cold.  I seemed to feel better after that initial period until 3/24 when while driving a hot flash came over me and the next day I was again in a type of brain fog.  For the next two days I tried to just deal with the brain fog but started to notice on the right side of my neck a feeling of constriction, with abnormally high blood pressure.  I went to the hospital ER and the completed a CAT scan of my brain and neck, blood work and urine work up with no evidence of why my neck was feeling constricted and high blood pressure.  The symptoms continued and on 4/1 my blood pressure  spike to 168/93 and I again went back to the hospital ER and spent the night.  I was having heart palpitations, anxiety and very high blood pressure.  The hospital this time completed more bloodwork, MRI of my brain and neck and an Eco-cardiogram.  I am now on 3 blood pressure and heart medications and have no diagnoses of why my blood pressure and heart rate are so abnormal.  I am very healthy and exercise daily and have never encountered this and my BP has always been extremely good.
40 year old male with local reaction to Anthrax. Swelling, itchiness, redness from site extending past elbow of lt arm.
Rash on face, rash on top of shoulders  all down my back.  Chest and down both arms to elbows. Red Itchy painful rash. Started  one day after first vacc and after second vacc  and had a rash for a total of 8 weeks.
Case number PHEH2014US024312, is an initial spontaneous report from a nurse received on 02 Dec 2014, with a follow up received from nurse on 19 Jan 2015. This report refers to a 64-year-old female patient. Her medical history was not reported. Concomitant medications were none. The patient was vaccinated with FLUVIRIN (batch number: 14511P, expiry date: Mar 2015) intramuscularly at a dose of 0.5 ml into the left deltoid on 05 Nov 2014. The nurse reported that before vaccination the prefilled syringe (PFS) of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. The patient did not experience any adverse reaction due to the maladministration. Follow up received from nurse on 19 Jan 2015: updated site of vaccination and reporter comment.
extreme itching on his lower legs,little itching on his ankles and feet; rash spread on most of his body,mild rash on his ankles and feet; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (extreme itching on his lower legs,little itching on his ankles and feet) and RASH (rash spread on most of his body,mild rash on his ankles and feet) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was updated by reporter.  Concomitant products included CHOLESTEROL for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced PRURITUS (extreme itching on his lower legs,little itching on his ankles and feet) and RASH (rash spread on most of his body,mild rash on his ankles and feet). At the time of the report, PRURITUS (extreme itching on his lower legs,little itching on his ankles and feet) and RASH (rash spread on most of his body,mild rash on his ankles and feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included medicine for blood pressure. Treatment included antihistamines, a steroid cream and a Benadryl cream.
Covid Arm.   swollen, hard, itchy 2/3 welt appeared exactly one week after injection. Over the next 2-3 days the swelling and itch spread around 3/4 of my arm. Now, exactly 2 weeks from the vaccination, the primary site is no longer very itchy and the swelling and redness are mostly gone unless irritated, but there is still itching on the flabby regions on the front and back of my arm. Fairly well controlled now with hydrocortisone.
Red, warm rash around injection site cold sweat, chills, and swelling to Left arm
Severe Body aches headache severe weakness sleeping constantly diarrhea abdominal pains dizziness nauseous
Patient given vaccine that was diluted incorrectly. Nurse diluted with 0.8mL instead of 1.8mL. No known adverse effects at this time.
Was actively breastfeeding with full feedings and ability to pump 3-4 oz post feeding.  Within 2 days my milk dried up without warning and I had to stop breastfeeding my 3 month old.  All attempts to increase milk supply have failed and breastfeeding came to an undesired full stop.
CLIENT ATTENDED CLINIC TO RECEIVE DTAP BOOSTER.  DOSE WAS ADMINSTERED AS INDICATED BUT UPON INPUTTING DATA INTO COMPUTER IT WAS DISCOVERED THAT DTAP HAD EXPIRED ON 10/11/2010.  CDC WAS CONTACTED AND ADVISED TO REVACCINATE.  NO ADVERSE AFFECTS WERE NOTED.
Myalgia, NauseaVomiting, itching inside ears Narrative: Employee stated after receiving 2nd vaccine she had severe myalgia around 1700 and around 2300 she began to have nausea and vomiting which lasted until 0115. Today she still has some myalgia which is not as severe and noticed itching inside her ears.
Did not mix both vials correctly, but instead administer saline solution alone; Did not mix both vials correctly, but instead administer saline solution alone; This non-serious case was reported by a nurse via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Did not mix both vials correctly, but instead administer saline solution alone) and inappropriate dose of vaccine administered (Verbatim: Did not mix both vials correctly, but instead administer saline solution alone).  The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 23-AUG-2023 The reporter reported that the office nurse incorrectly administered the Shingrix vaccine to the patient which did not mix both vials correctly and administered saline solution alone Only saline solution of shingrix administered to patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up.
Pt tensed up like a seizure was happening and fell towards me out of chair. Pt then went to the ground and regained awareness. EMS was called and she was released by the medics.
Information has been received from a physician concerning a teenager female who on an unspecified date was vaccinated with the first dose of GARDASIL. There was no concomitant medication. Subsequently the patient experienced dizzy for a week. It was worst in the mornings. The patient decided not to complete the series. Subsequently, the patient recovered from dizzy. The patient sought unspecified medical attention. Additional information has been requested.
Patient started having memory loss about a month after receiving second dose of Moderna according to husband.  She has been refered to a neurologist.  Has had an MRI showing no evivence of alzheimer' saccording to husband.  She is now taking Aricept.
Started with itching on my palms and soles of my feet, progressing over the next couple of weeks to overall itchiness, redness, lesions, dermagraphism, burning, and hives. I have been to primary care doc, endocrinologist, allergist, dermatologist, and rheumatologist. I was instructed to take round-the-clock antihistamines, which I have been doing since May 2023. They mostly control my symptoms, but if I stop taking them, the hives return within about 12 hours.
26 Patient received a vaccine expired on 16-Apr-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (26 Patient received a vaccine expired on 16-Apr-2022) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007J21-2a) for COVID-19 vaccination.     Patient does not have any allergies or other chronic conditions. The patient never had COVID positive test or diagnosis.  Patient didn't received any other vaccines within 1 month prior to Moderna COVID-19 vaccine.     On 20-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (26 Patient received a vaccine expired on 16-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (26 Patient received a vaccine expired on 16-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  The received first booster dose. It was unknown whether seek medical care or whether the patient experienced a similar event in the past.  No treatment medication information was provided.
The pain went across to my left breast  and it was tender to the touch; Under left arm, the armpit, pain and swelling; Swelling in armpit; pain across to my left breast; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (pain across to my left breast), BREAST TENDERNESS (The pain went across to my left breast  and it was tender to the touch), AXILLARY PAIN (Under left arm, the armpit, pain and swelling) and LYMPHADENOPATHY (Swelling in armpit) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939903, 031L20A and 027A21A) for COVID-19 vaccination.     No Medical history information was reported.  Concomitant products included ATORVASTATIN CALCIUM (ATORVASTATIN +PHARMA) for Cholesterol, LEVOTHYROXINE for Thyroxine, VITAMIN D NOS, VITAMIN E NOS, ASCORBIC ACID (VITAMIN C ACID) and ACETYLSALICYLIC ACID (ASPIRIN ACTAVIS) for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, the patient experienced BREAST PAIN (pain across to my left breast), AXILLARY PAIN (Under left arm, the armpit, pain and swelling) and LYMPHADENOPATHY (Swelling in armpit). On 29-Oct-2021, the patient experienced BREAST TENDERNESS (The pain went across to my left breast  and it was tender to the touch). The patient was treated with PARACETAMOL (TYLENOL A) for Adverse event, at an unspecified dose and frequency. On 03-Nov-2021, AXILLARY PAIN (Under left arm, the armpit, pain and swelling) and LYMPHADENOPATHY (Swelling in armpit) had resolved. At the time of the report, BREAST PAIN (pain across to my left breast) had not resolved and BREAST TENDERNESS (The pain went across to my left breast  and it was tender to the touch) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient new event include  pain went across to my left breast  and it was tender to the touch and outcome of the event is not recovered or resolved.   This case was linked to MOD-2021-370048 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Nov-2021: Significant Follow up event added and Under left arm, the armpit, pain and swelling event outcome was updated and  patient demographic details added.
17 hours after vaccine I got fever 101.8 with 10/10 body aches for four days even with ibuprofen and Tylenol. 4 days after vaccine a I  had mouth/teeth pain     I also lost my ability to speak fluently.  I now have to talk very slowly searching for my words sounding robotic.
Swelling of my face and throat, dizziness, injection site pain, arm pain, headache, tiredness, muscle pain, feeling unwell, shortness of breath  a little bit
Though not due to the vaccine, I came down with COVID-19 on 11/1/2022 Became ill on 11/1/22, tested positive for COVID on 11/3/22, Received/started Nirmatrelvir-Ritonavir on 11/5/22. Symptoms: tired, ached, diarrhea, foggy brain, difficulty breathing. Was sick for two solid weeks, after which I experienced low blood pressure (to the point I felt unsafe to drive). Spoke with Dr. on 11/16/22.  A week later I started having difficulty breathing.  It progressively got worse.  Called Dr.'s office who referred me to the emergency room on 11/28/22.
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a Pfizer-sponsored program. A contactable female healthcare professional of unspecified age reported that she received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 15Jan2021, for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. On 18Jan2021 the patient tested positive. She said that she was likely exposed already and had it when she got the first dose of the vaccine. She was asking if she can still get the second dose, she will be out of the quarantine on 28Jan2021. Event outcome was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID-19 test positive based on the known safety profile. However the short duration of 3 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity.
shingles; This spontaneous report has been received from a lawyer, regarding a case in litigation and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date in 2014, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiry date were not provided) as prescribed and/or administered by a healthcare provider at the physician's office for the long-term prevention of shingles and zoster-related conditions. Subsequent to the patient's zoster vaccine live (ZOSTAVAX) inoculation, on an unknown date, the patient was treated by a healthcare provider at the physician's office for shingles. As a direct and proximate result of the patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of shingles was considered to be medically significant. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
INFLAMMATION, ITCHING, HIVES ALONG VARIOUS PARTS OF LEFT ARM (ARM IN WHICH FLU SHOT WAS RECEIVED); TOOK ZYRTEC, BUT DID NOT HELP. WENT TO AN CLINIC FOR STEROID SHOT & BEGAN COURSE OF PREDNISONE THEREAFTER.
pt stated that her left arm was sore the next day after getting the vax but about 7 days later she developed a warm, red, itchy bump around injection site that is about the size of a quarter.
pt c/o of diarrhea, nausea, & fever of 101.3;